These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6500384)
21. Antithrombotic Activity of a Novel Diazepino[1,2-α] Benzimidazole Derivative on Arterial Thrombosis Model in Rats without Concomitant Pathology and in Rats with Experimental Myocardial Infarction. Spasov AA; Kucheryavenko AF; Sirotenko VS; Anisimova VA; Divaeva LN; Kuz'menko TA; Morkovnik AS Bull Exp Biol Med; 2019 Apr; 166(6):747-750. PubMed ID: 31020589 [TBL] [Abstract][Full Text] [Related]
22. Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis. Philp RB; Francey I; Warren BA Haemostasis; 1978; 7(5):282-93. PubMed ID: 689491 [TBL] [Abstract][Full Text] [Related]
23. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Schrör K Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351 [TBL] [Abstract][Full Text] [Related]
24. Characterization of a unique dihydropyrimidinone, ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model. Priya N; Singh P; Bhatia S; Medhi B; Prasad AK; Parmar VS; Raj HG J Pharm Pharmacol; 2011 Sep; 63(9):1175-85. PubMed ID: 21827490 [TBL] [Abstract][Full Text] [Related]
25. Effect of cilostazol on platelet aggregation and experimental thrombosis. Kimura Y; Tani T; Kanbe T; Watanabe K Arzneimittelforschung; 1985; 35(7A):1144-9. PubMed ID: 4074426 [TBL] [Abstract][Full Text] [Related]
27. Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests. Kammerer I; Bach J; Saggau W; Isgro F Thorac Cardiovasc Surg; 2011 Oct; 59(7):425-9. PubMed ID: 21437867 [TBL] [Abstract][Full Text] [Related]
28. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals. Momo K; Someya K; Tachiiri T; Mitsuoka Y; Nakamura K; Imai S; Ino T; Ohkubo H Arzneimittelforschung; 1992 Jan; 42(1):32-9. PubMed ID: 1586377 [TBL] [Abstract][Full Text] [Related]
29. Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling. Gong Y; Lin M; Piao L; Li X; Yang F; Zhang J; Xiao B; Zhang Q; Song WL; Yin H; Zhu L; Funk CD; Yu Y Br J Pharmacol; 2015 Dec; 172(23):5647-60. PubMed ID: 25339093 [TBL] [Abstract][Full Text] [Related]
30. Thrombosis prevention by acetylsalicylic acid in hyperlipemic rats. Renaud S; Godu J Can Med Assoc J; 1970 Nov; 103(10):1037-40. PubMed ID: 5531310 [TBL] [Abstract][Full Text] [Related]
31. Non-interference by salicylate with aspirin inhibition of arterial thrombosis in rats. Philp RB; Paul ML Prostaglandins Med; 1981 Aug; 7(2):91-4. PubMed ID: 6792646 [TBL] [Abstract][Full Text] [Related]
32. Prevention of arterial thrombosis by edoxaban, an oral factor Xa inhibitor in rats: monotherapy and in combination with antiplatelet agents. Honda Y; Kamisato C; Morishima Y Eur J Pharmacol; 2016 Sep; 786():246-252. PubMed ID: 27288116 [TBL] [Abstract][Full Text] [Related]
33. [Experimental antithrombotic activity of oral isosorbide dinitrate]. Plotkine M; Allix M; Guillou J; Boulu R Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():57-60. PubMed ID: 1530431 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of the antithrombotic effects of pentoxifylline, acetylsalicylic acid and low molecular weight heparin in the laser model of thrombosis]. Krupiński K; Breddin HK; Bielawiec M; Płonowski A Kardiol Pol; 1992 Mar; 36(3):142-5. PubMed ID: 1318982 [TBL] [Abstract][Full Text] [Related]
35. The synergistic effect of aspirin and dipyridamole upon platelet thrombi in living blood vessels. Honour AJ; Hockaday TD; Mann JI Br J Exp Pathol; 1977 Jun; 58(3):268-72. PubMed ID: 871376 [TBL] [Abstract][Full Text] [Related]
36. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study. Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469 [TBL] [Abstract][Full Text] [Related]
37. Surprising effects of the sequential administration of pentoxifylline and low dose acetylsalicylic acid on thrombus formation. Seiffge D; Weithmann KU Thromb Res; 1987 Apr; 46(2):371-83. PubMed ID: 3603430 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the inhibitory effects of acetylsalicylic acid and trifusal on enzymes related to thrombosis. Garcia Rafanell J; Planas JM; Puig-Parellada P Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):343-50. PubMed ID: 226020 [TBL] [Abstract][Full Text] [Related]
39. Correlation between bleeding time and antithrombotic effect of platelet-suppressive agents in rat experimental model. Suehiro A; Oura Y; Ueda M; Kakishita E Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):157-63. PubMed ID: 8202629 [TBL] [Abstract][Full Text] [Related]
40. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition. Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]